TRIM9 anticorps (N-Term)
Aperçu rapide pour TRIM9 anticorps (N-Term) (ABIN6265743)
Antigène
Voir toutes TRIM9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- TRIM9 Antibody detects endogenous levels of total TRIM9.
-
Homologie
- Pig,Zebrafish,Bovine,Sheep,Rabbit,Dog,Chicken
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogène
- A synthesized peptide derived from human TRIM9, corresponding to a region within N-terminal amino acids.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C. Stable for 12 months from date of receipt.
-
Date de péremption
- 12 months
-
-
- TRIM9 (Tripartite Motif Containing 9 (TRIM9))
-
Autre désignation
- TRIM9
-
Sujet
-
Description: E3 ubiquitin-protein ligase which ubiquitinates itself in cooperation with an E2 enzyme UBE2D2/UBC4 and serves as a targeting signal for proteasomal degradation. May play a role in regulation of neuronal functions and may also participate in the formation or breakdown of abnormal inclusions in neurodegenerative disorders. May act as a regulator of synaptic vesicle exocytosis by controlling the availability of SNAP25 for the SNARE complex formation.
Gene: TRIM9
-
Poids moléculaire
- 90 kDa, 61 kDa
-
ID gène
- 114088
-
UniProt
- Q9C026
-
Pathways
- Synaptic Vesicle Exocytosis
Antigène
-